Optimized Adenoviral Vector That Enhances the Assembly of FMDV O1 Virus-Like Particles in situ Increases Its Potential as Vaccine for Serotype O Viruses-Reference-Cited by-同舟云学术

Optimized Adenoviral Vector That Enhances the Assembly of FMDV O1 Virus-Like Particles in situ Increases Its Potential as Vaccine for Serotype O Viruses

Published:2020-11-04 Issue: Volume:11 Page:
ISSN:1664-302X
Container-title:Frontiers in Microbiology
language:
Short-container-title:Front. Microbiol.

Author:

Ziraldo Micaela,Bidart Juan E.,Prato Cecilia A.,Tribulatti María V.,Zamorano Patricia,Mattion Nora,D’Antuono Alejandra L.

Funder

Fondo para la Investigación Científica y Tecnológica

Publisher

Frontiers Media SA

Subject

Microbiology (medical),Microbiology

Reference87 articles.

1. Image processing with ImageJ.;Abramoff;Biophoton. Int.,2004

2. ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules.;Ashkenazy;Nucleic Acids Res.,2016

3. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production.;Bahnemann;Arch. Virol.,1975

4. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.;Barrera;Vaccine,2018

5. ConSeq: The identification of functionally and structurally important residues in protein sequences.;Berezin;Bioinformatics,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Application of Adenovirus (AdV): A Comprehensive Review;Viruses;2024-07-08

2. Development of Foot-and-Mouth Disease Vaccines in Recent Years;Vaccines;2022-10-28

3. Plant holobiont interactions mediated by the type VI secretion system and the membrane vesicles: promising tools for a greener agriculture;Environmental Microbiology;2021-03-23

4. Salmonella Vaccine Vector System for Foot-and-Mouth Disease Virus and Evaluation of Its Efficacy with Virus-Like Particles;Vaccines;2021-01-05